J2361 Injection, depemokimab-ulaa, 1 mg

Billable / valid for submission HCPCS Release 2026Q3

Short description: Inj depemokimab-ulaa 1 mg

Version history

Related codes in J23

• J2300 Injection, nalbuphine hydrochloride, per 10 mg
• J2305 Injection, nitroglycerin, 5 mg
• J2312 Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg
• J2313 Injection, naloxone hydrochloride (zimhi), 0.01 mg
• J2315 Injection, naltrexone, depot form, 1 mg
• J2320 Injection, nandrolone decanoate, up to 50 mg
• J2323 Injection, natalizumab, 1 mg
• J2325 Injection, nesiritide, 0.1 mg
• J2326 Injection, nusinersen, 0.1 mg
• J2327 Injection, risankizumab-rzaa, intravenous, 1 mg
• J2329 Injection, ublituximab-xiiy, 1mg
• J2350 Injection, ocrelizumab, 1 mg
• J2351 Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq
• J2353 Injection, octreotide, depot form for intramuscular injection, 1 mg
• J2354 Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg
• J2355 Injection, oprelvekin, 5 mg
• J2356 Injection, tezepelumab-ekko, 1 mg
• J2357 Injection, omalizumab, 5 mg
• J2358 Injection, olanzapine, long-acting, 1 mg
• J2359 Injection, olanzapine, 0.5 mg

All J23 codes →